If compared to tacrine, an anti-AD drug with a similar structure discontinued from therapeutic use in 2013 [35,36,37], AMQ and 7 are equally potent inhibitors of AChE, while 5 is even two times more potent. This evidence concerns the gene ACHE and Alzheimer disease.